SCHEMBL30634146

SCHEMBL30634146

O=C(NCc1ccc(Cl)cc1)NC1CC2(CC(CN3CCC[C@@H]3c3cccnc3)C2)C1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ EPHX1 P07099 1/20 0.45
▸ ALDH1A1 P00352 4/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ TSHR P16473 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ GAA P10253 2/20 0.43
▸ HTT P42858 1/20 0.43
▸ MEN1 O00255 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ OPRK1 P41145 5/20 0.42
▸ OPRM1 P35372 4/20 0.42
▸ OPRD1 P41143 2/20 0.42
▸ MAPT P10636 1/20 0.40
▸ ADAM17 P78536 1/20 0.40
▸ LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26633678 1.00 L3MBTL1 (0.47) L3MBTL1EPHX1ALDH1A1KDM4ETSHR
SCHEMBL24011439 0.91 EPHX1 (0.50) L3MBTL1EPHX1ALDH1A1KDM4ETSHR
SCHEMBL30306690 0.83 ALDH1A1 (0.48) ALDH1A1KDM4ETSHRSMN1; SMN2GAA
SCHEMBL26633732 0.79 RAB9A (0.53) EPHX1ALDH1A1TSHRSMN1; SMN2HPGD
SCHEMBL26764484 0.78 KMT2A (0.51) L3MBTL1EPHX1ALDH1A1KDM4ETSHR
SCHEMBL26633749 0.78 EPHX1 (0.43) EPHX1MEN1HPGDKMT2A
SCHEMBL30634168 0.75 LMNA (0.53) L3MBTL1ALDH1A1KDM4ESMN1; SMN2GAA
SCHEMBL30288085 0.75 LMNA (0.53) L3MBTL1ALDH1A1KDM4ESMN1; SMN2GAA
SCHEMBL26633838 0.75 LMNA (0.53) L3MBTL1ALDH1A1KDM4ESMN1; SMN2GAA
SCHEMBL26633844 0.75 LMNA (0.53) L3MBTL1ALDH1A1KDM4ESMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348369-A1 NAMPT MODULATORS NAMPT, NNT, NAPRT L3MBTL1 3643/4885EPHX1 3913/4885ALDH1A1 982/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback